Skip to main content
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.450
+0.020 (1.40%)
Feb 21, 2025, 4:00 PM EST - Market closed

Lexaria Bioscience Revenue

Lexaria Bioscience had revenue of $183.92K in the quarter ending November 30, 2024, with 21.58% growth. This brings the company's revenue in the last twelve months to $496.92K, up 77.63% year-over-year. In the fiscal year ending August 31, 2024, Lexaria Bioscience had annual revenue of $464.28K with 105.24% growth.

Revenue (ttm)
$496.92K
Revenue Growth
+77.63%
P/S Ratio
41.69
Revenue / Employee
$70,989
Employees
7
Market Cap
25.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 2024464.28K238.07K105.24%
Aug 31, 2023226.21K-29.19K-11.43%
Aug 31, 2022255.40K-467.34K-64.66%
Aug 31, 2021722.74K407.95K129.59%
Aug 31, 2020314.79K92.18K41.41%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

LEXX News

More News